Rebif
interferon beta-1a · KIT · EMD Serono, Inc.
No Recall History
Plain English
Rebif is a kit containing interferon beta-1a, taken subcutaneous. Manufactured by EMD Serono, Inc..
Key Facts
- Brand Name
- Rebif
- Generic Name
- interferon beta-1a
- NDC Code (Product)
44087-8822- Manufacturer
- EMD Serono, Inc.
- Dosage Form
- KIT
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA103780
- Drug Class
- Interferon beta [EPC]
- Marketing Start
- 12/17/2004
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
multiple sclerosis relapse4,078 reports
fatigue2,990 reports
injection site erythema2,956 reports
influenza like illness2,932 reports
fall2,550 reports
headache2,452 reports
injection site pain2,428 reports
pain1,932 reports
depression1,844 reports
multiple sclerosis1,773 reports
Frequently Asked Questions
What is Rebif used for?
Rebif contains interferon beta-1a. It is a kit taken subcutaneous. Consult your doctor for specific uses.
Is Rebif a controlled substance?
Rebif is not classified as a controlled substance by the DEA.
What is the generic name for Rebif?
The generic name for Rebif is interferon beta-1a. There are 9 other brand versions of interferon beta-1a.
What is the NDC code for Rebif ?
The NDC (National Drug Code) for Rebif is 44087-8822, listed by EMD Serono, Inc..